Tarsus Pharmaceuticals: Unlocking Growth Potential With Eye Care Innovations
Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...
Nottingham woman whose breast implants burst says plastic surgery clinic deleted her medical records
A Nottingham woman says a plastic surgery clinic told her they had deleted her medical records before she underwent an urgent ...
InStyle3d
The Makers of Botox Are Behind an Eye Cream That Brightened My Dark Circles
A beauty editor is making three swaps in her skin care routine for fall. Shop Cosrx, SkinMedica, and Superegg on Amazon ...
JD Supra3d
Federal Circuit Provides Clarity On Proper Obviousness-Type Double Patenting References
In Allergan USA, Inc. et al., v. MSN Laboratories Private Ltd., et al., the United States Court of Appeals for the Federal Circuit issued a precedential decision relating to obviousness-type double ...
InStyle5d
My Go-To Skin-Plumping Treatment From the Makers of Botox Just Got Even Better
SkinMedica, from the makers of Botox, recently revamped one of its star products with the addition of collagen. I tested the ...
Orange County Business Journal5d
NovoThelium Wins ULP’s Golden Ticket Pitch Contest
The San Antonio, Texas-based company said it has found a way to use donor tissue for nipple reconstruction following a ...
JD Supra6d
Federal Circuit Weighs in Again on Obviousness-Type Double Patenting to Limit In re Cellect and Preserve PTA for First-Filed, First-Issued Patents
Obviousness-type double patenting (ODP), a judicially-created ground of patent invalidity, has become the subject of intense ...
Bausch + Lomb's stock soars 14% on report company is considering selling itself
The stock of eyecare company Bausch + Lomb Corp. was up 14%on Monday, after the Financial Times reported that the company is considering selling itself as a way to extricate itself from its indebted ...
Federal Circuit Decision Clarifies Obviousness-Type Double Patenting and Patent Term Adjustments In 'Allergan v. MSN Laboratories'
On August 13, the Federal Circuit issued a precedential ruling that reversed the District of Delaware’s application of the ...
Baltimore Banner6d
Baltimore settles opioid lawsuit with Johnson & Johnson ahead of trial against drug companies
Details of the settlement between Baltimore and Johnson & Johnson remain secret, unlike previous opioid settlements that the ...
Is Pfizer Stock A Better Pick Over AbbVie?
Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer – AbbVie stock (NYSE:ABBV). PFE stock trades at a much lower multiple of 11x ...